NCT00346892View on ClinicalTrials.gov

To Evaluate 2 Doses of GSK Biologicals' Oral Live Attenuated Human HRV Vaccine Co-administered With Either OPV or IPV

PHASE2CompletedINTERVENTIONAL
Enrollment

450

Participants

Timeline

Start Date

November 30, 2001

Primary Completion Date

March 31, 2003

Conditions
Rotavirus Infections
Interventions
BIOLOGICAL

Rotavirus (vaccine)

Trial Locations (1)

Unknown

Pretoria

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY